Function, Therapeutic Potential, and Inhibition of Hsp70 Chaperones

Andrew J. Ambrose, Eli Chapman

Research output: Contribution to journalReview articlepeer-review

Abstract

Hsp70s are among the most highly conserved proteins in all of biology. Through an iterative binding and release of exposed hydrophobic residues on client proteins, Hsp70s can prevent aggregation and promote folding to the native state of their client proteins. The human proteome contains eight canonical Hsp70s. Because Hsp70s are relatively promiscuous they play a role in folding a large proportion of the proteome. Hsp70s are implicated in disease through their ability to regulate protein homeostasis. In recent years, researchers have attempted to develop selective inhibitors of Hsp70 isoforms to better understand the role of individual isoforms in biology and as potential therapeutics. Selective inhibitors have come from rational design, forced localization, and serendipity, but the development of completely selective inhibitors remains elusive. In the present review, we discuss the Hsp70 structure and function, the known Hsp70 client proteins, the role of Hsp70s in disease, and current efforts to discover Hsp70 modulators.

Original languageEnglish (US)
Pages (from-to)7060-7082
Number of pages23
JournalJournal of Medicinal Chemistry
Volume64
Issue number11
DOIs
StatePublished - Jun 10 2021

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Function, Therapeutic Potential, and Inhibition of Hsp70 Chaperones'. Together they form a unique fingerprint.

Cite this